BioXconomy is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Events
Advertise
Stay Updated
Stay Updated
Investment
Related Topics
VC/PE
Seed Funding
IPOs
Recent in
Investment
See All
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
by
Richard Daverman
Nov 18, 2024
5 Min Read
CMO Summit in Milan, Italy
Investment
IPOs on course for recovery but does biotech need public funding anymore?
IPOs on course for recovery but does biotech need public funding anymore?
by
Dan Stanton
Nov 12, 2024
4 Min Read
Innovation
Related Topics
Hubs
Academic Research
R&D Technology
Recent in
Innovation
See All
coloured pencils
Innovation
Nonprofit looks to bring tomorrow’s science into today’s classrooms
Nonprofit looks to bring tomorrow’s science into today’s classrooms
by
Millie Nelson
Nov 11, 2024
4 Min Read
Asian currency
Innovation
Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
by
Richard Daverman
Oct 21, 2024
4 Min Read
Partnering
Related Topics
Licensing
M&A
Deals
Best Practices
Recent in
Partnering
See All
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
by
Millie Nelson
Nov 19, 2024
3 Min Read
Panelists Anta Gkelou Partner, Sofinnova Partners; Bobby Soni CIO, BioInnovation Institute; Renee Lucander CEO, Calliditas Therapeutics
Partnering
Successful mentorship between investors and CEOs hangs on respect
Successful mentorship between investors and CEOs hangs on respect
Nov 15, 2024
5 Min Read
Business Strategy
Related Topics
Scaling/Commercialization
Growth Strategy
ESG
Outsourcing
Legal
Recent in
Business Strategy
See All
thumbnail
Business Strategy
Build trust by making healthcare fairer and more equitable, say experts
Build trust by making healthcare fairer and more equitable, say experts
by
Millie Nelson
Oct 14, 2024
3 Min Read
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reform
The sustainability series: Reflect, rethink, and reform
by
Millie Nelson
Oct 11, 2024
14 Min Read
Home
Millie Nelson
Millie Nelson
Editor, BioXconomy
Latest from Millie Nelson
A whiteboard saying transition
Investment
From Series A to B: Navigating the transition from promise to proof
From Series A to B: Navigating the transition from promise to proof
by
Millie Nelson
Nov 20, 2024
3 Min Read
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
by
Millie Nelson
Nov 19, 2024
3 Min Read
All from Millie Nelson
Innovation
Nonprofit looks to bring tomorrow’s science into today’s classrooms
Nonprofit looks to bring tomorrow’s science into today’s classrooms
Nov 11, 2024
|
4 Min Read
by
Millie Nelson
Seed Funding
Europe’s adversity to risk is why the US is ahead, say experts
Europe’s adversity to risk is why the US is ahead
Nov 5, 2024
|
3 Min Read
by
Millie Nelson
Investment
Call for specific female health funding to tackle biotech finance gender gap
Call for specific female health funding to tackle biotech finance gender gap
Oct 30, 2024
|
2 Min Read
by
Millie Nelson
Partnering
AbbVie forks out $1.4bn to buy Alzheimer’s therapy developer Aliada
AbbVie forks out $1.4bn to buy Aliada
Oct 29, 2024
|
2 Min Read
by
Millie Nelson
Investment
What’s your secret sauce? VC’s on what makes a compelling pitch
VC’s on what makes a compelling pitch
Oct 24, 2024
|
3 Min Read
by
Millie Nelson
Innovation
From east to west: Lilly plans incubators in China and UK
From east to west: Lilly plans incubators in China and UK
Oct 18, 2024
|
2 Min Read
by
Millie Nelson,
Richard Daverman
Investment
The rise of radiopharmaceuticals sees big pharma back Aktis’ $175m Series B
The rise of radiopharmaceuticals sees big pharma back Aktis’ $175m Series B
Oct 17, 2024
|
2 Min Read
by
Millie Nelson
Business Strategy
Build trust by making healthcare fairer and more equitable, say experts
Build trust by making healthcare fairer and more equitable, say experts
Oct 14, 2024
|
3 Min Read
by
Millie Nelson
Business Strategy
The sustainability series: Reflect, rethink, and reform
The sustainability series: Reflect, rethink, and reform
Oct 11, 2024
|
14 Min Read
by
Millie Nelson
Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Oct 1, 2024
|
2 Min Read
by
Millie Nelson
Investment
$325 million Series C funding in its Arsenal (Biosciences)
$325 million Series C funding in its Arsenal (Biosciences)
Sep 25, 2024
|
1 Min Read
by
Millie Nelson
Partnering
Want to be a partner of choice? Distinguish yourself in the space
Want to be a partner of choice? Distinguish yourself in the space
Sep 25, 2024
|
4 Min Read
by
Millie Nelson
Partnering
To be truly great you need to partner, says J&J
To be truly great you need to partner, says J&J
Sep 25, 2024
|
7 Min Read
by
Millie Nelson
Partnering
RayzeBio: A Christmas to remember
RayzeBio: A Christmas to remember
Sep 25, 2024
|
3 Min Read
by
Millie Nelson
Partnering
Prometheus and Merck: Under the bonnet of the largest pre-Phase III M&A deal
Under the bonnet of the largest pre-Phase III M&A deal
Sep 25, 2024
|
6 Min Read
by
Millie Nelson
Partnering
Bayer and NextRNA: One partnership, two oncology programs
Bayer and NextRNA: One partnership, two oncology programs
Sep 25, 2024
|
3 Min Read
by
Millie Nelson
Partnering
BioNTech: Partnerships are key to deliver drugs at scale
BioNTech: Partnerships are key to deliver drugs at scale
May 20, 2024
|
2 Min Read
by
Millie Nelson
Innovation
From healthcare to health: 'No country can do this alone,' say experts in UAE
'No country can do this alone,' say experts in UAE
May 14, 2024
|
2 Min Read
by
Millie Nelson
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
2 Min Read
by
Millie Nelson
Partnering
Perfect match: Picking your CDMO is like a marriage, says Bayer
Picking your CDMO is like a marriage, says Bayer
Apr 11, 2024
|
2 Min Read
by
Millie Nelson
Partnering
Competitor today, friend tomorrow: Why partnering is critical for biopharma success
Why partnering is critical for biopharma success
Apr 5, 2024
|
4 Min Read
by
Millie Nelson
Innovation
GLP-1 boom causing pharma players FOMO
GLP-1 boom causing pharma players FOMO
Mar 25, 2024
|
2 Min Read
by
Millie Nelson
Business Strategy
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies
Feb 26, 2024
|
7 Min Read
by
Millie Nelson
Innovation
GSK, Novartis, Calliditas among winners at LSX Awards
GSK, Novartis, Calliditas among winners at LSX Awards
Nov 16, 2023
|
3 Min Read
by
Millie Nelson
Business Strategy
Testing times: MilliporeSigma talks CDMO competition
Testing times: MilliporeSigma talks CDMO competition
Oct 11, 2023
|
3 Min Read
by
Millie Nelson
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMO
Experts on when you should dump your CDMO
Sep 22, 2023
|
1 Min Read
by
Millie Nelson
Business Strategy
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
2 Min Read
by
Millie Nelson
Business Strategy
Webinar
Cracking the code: Mastering biopharma launches in Europe
Register Now
News from APAC
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
by
Richard Daverman
Nov 18, 2024
5 Min Read
Money
Investment
Eyes on Asia: Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
by
Richard Daverman
Nov 5, 2024
3 Min Read
Reverse arrow
Partnering
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
by
Richard Daverman
Oct 31, 2024
3 Min Read
Recommended
Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated
